Evidence map›Paper›PMID 38544346›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Dual Activity of Type III PI3K Kinase Vps34 is Critical for NK Cell Development and Senescence.

Shasha Chen, Zehua Li, Jin Feng, Yuhe Quan, Junming He, Jiqing Hao, Zhongjun Dong

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Shasha ChenDepartment of Allergy, The First Affiliated Hospital of Anhui Medical University and Institute of Clinical Immunology, Anhui Medical University, Hefei, 230032, China.
Zehua LiState Key Laboratory of Membrane Biology, School of Medicine and Institute for Immunology, Tsinghua University, Beijing, 100084, China.
Jin FengState Key Laboratory of Membrane Biology, School of Medicine and Institute for Immunology, Tsinghua University, Beijing, 100084, China.
Yuhe QuanState Key Laboratory of Membrane Biology, School of Medicine and Institute for Immunology, Tsinghua University, Beijing, 100084, China.
Junming HeState Key Laboratory of Membrane Biology, School of Medicine and Institute for Immunology, Tsinghua University, Beijing, 100084, China.
Jiqing HaoDepartment of Allergy, The First Affiliated Hospital of Anhui Medical University and Institute of Clinical Immunology, Anhui Medical University, Hefei, 230032, China.
Zhongjun DongDepartment of Allergy, The First Affiliated Hospital of Anhui Medical University and Institute of Clinical Immunology, Anhui Medical University, Hefei, 230032, China.ORCID 0000-0002-2155-231X
Tsinghua University · CNAnhui Medical University · CN

Funding

Anhui Provincial Department of Education 2022AH030114Anhui Provincial Department of Education 2023AH010085Ministry of Science and Technology of the People's Republic of China 2022YFF0710600National Key Research and Developmental Program of China 2022YFF0710602National Natural Science Foundation of China 32330034National Natural Science Foundation of China 82103327Tsinghua University Initiative Scientific Research Program of Precision Medicine 2023ZLA002
6 · The paper itself

Abstract

Vps34 is the unique member of the class III phosphoinositide 3-kinase family that performs both vesicular transport and autophagy. Its role in natural killer (NK) cells remains uncertain. In this study, a model without Vps34 (Vps34

Indexed as

Cell DifferentiationCellular SenescenceClass III Phosphatidylinositol 3-KinasesKiller Cells, NaturalAnimalsAutophagyMiceClass III Phosphatidylinositol 3-KinasesPIK3C3 protein, mouseautophagyCD122IL‐15NK cellsenescenceVps34

Identifiers

PMID38544346
PMCPMC11151045
OpenAlexW4393273168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.